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Abstract 
In  normal  human  cells,  oncogene-induced  senescence  (OIS)  depends  on  induction  of 
DNA damage response (DDR). Oxidative stress and hyper-replication of genomic DNA have 
been  proposed  as  major  causes  of  DNA  damage  in  OIS  cells.    Here  we  report  that  down-
regulation  of  deoxyribonucleoside  pools  is  another  endogenous  source  of  DNA  damage  in 
normal human fibroblasts (NHF) undergoing HRAS
G12V-induced senescence. NHF-HRAS
G12V 
cells  under-expressed  thymidylate  synthase  (TS)  and  ribonucleotide  reductase  (RR),  two 
enzymes required for the entire de novo deoxyribonucleotide biosynthesis, and possessed low 
dNTP levels. Chromatin at the promoters of the genes encoding TS and RR was enriched with 
RB tumor suppressor protein and histone H3 tri-methylated at lysine 9.  Importantly, ectopic co-
expression of TS and RR or addition of deoxyribonucleosides substantially  suppressed DNA 
damage,  senescence-associated  phenotypes  and  proliferation  arrest  in  two  types  of  NHF 
expressing HRAS
G12V. Reciprocally, shRNA-mediated suppression of TS and RR caused DNA 
damage  and  senescence  in  NHF  although  less  efficiently  than  HRAS
G12V.  However, 
overexpression of TS and RR in quiescent NHF did not overcome proliferation arrest, suggesting 
that unlike quiescence, OIS requires depletion of dNTP pools and activated DNA replication.  
Our data identify a previously unknown role of deoxyribonucleotides in regulation of oncogene-
induced senescence. 
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Introduction 
Oncogene-induced  senescence  represents  an  important  fail-safe  mechanism  that 
suppresses proliferation of pre-malignant cells (1-3).  Compelling evidence suggests that the 
response to DNA damage is one of the intrinsic processes required for the induction of OIS (4-
7).  It has been shown that aberrant activation of HRAS in human fibroblasts induces hyper-
replication of genomic DNA which leads to alterations in progression of DNA replication fork, 
generation of single and double strand DNA breaks (SSB and DSB, respectively) and activation 
of DNA damage response (DDR) (6). SSB induce DDR by engaging serine/threonine-protein 
kinase  ATR  (ataxia  telangiectasia  and  Rad3-related  protein)  that  transmits  signaling  to 
checkpoint  kinase  1  (CHK1)  (8).  CHK1  phosphorylates  CDC25  protein,  one  of  the  key 
regulators of cell cycle progression, and targets it for degradation (8).  DSB initiate DDR that 
depends on another serine/threonine protein kinase, ATM (ataxia telangiectasia mutated) (9).  
Activation  of  ATM  results  in  phosphorylation  of  several  targets,  including  the  histone  H2A 
variant H2AX (10), p53 tumor suppressor (11, 12) and CHK2 kinase (13).  Both ATR and ATM 
signaling pathways  are activated  in normal  human  fibroblasts (NHF) undergoing HRAS
G12V-
induced senescence (4-7), while ATM and CHK2 are required for this senescence since their 
individual shRNA-mediated inhibition enabled NHF to overcome proliferation arrest and other 
senescence-associated phenotypes (6,7).   
  At the same time, studies conducted in  yeasts and  mammalian  cells demonstrate that 
stalling of DNA replication fork and activation of ATR/CHK1 and ATM/CHK2 pathways can be 
induced by pharmacological depletion of all or selected nucleotide pools (14, 15). In the present 
study, we  investigated  endogenous processes that caused DNA damage  in  human  fibroblasts 
undergoing oncogene-induced senescence and demonstrated that DNA damage at least partially                                                                                                                
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originates  from  under-expression  of  key  enzymes  involved  in  de  novo  deoxyribonucleoside 
biosynthesis and subsequent depletion of endogenous dNTP pools.  We propose that nucleotide 
deficiency caused by aberrant expression of activated HRAS contributes to oncogene-induced 
senescence. 
 
Materials and Methods 
Cell lines and populations 
Normal  human  fibroblasts  WI-38  were  purchased  from  ATCC.  BJ-ET-RAS
G12V-ER
TAM 
fibroblasts  were  a  gift  from  Dr.  Andrei  Gudkov  (RPCI).  Cells  were  cultured  in  Dulbecco’s 
modified Eagle’s essential minimal medium supplemented with fetal calf serum (10%), 2 mM 
glutamine, and 100 units/ml penicillin G + 100 g/ml streptomycin.   
 
Lentiviral constructs and infection 
 Lentiviral  infection  protocols  and  vectors  containing  cDNAs  of  HRAS
G12V  were  described 
previously (16). pLKO1 vector containing shRNA for RR2  was purchased from Sigma Aldrich.  
cDNA for TS, RR1 and RR2 were amplified by reverse-transcription polymerase chain reaction 
from total RNA isolated from human melanoma cells and cloned in pLV-SV-puro expression 
vector (a gift from Dr. Peter Chumakov, Cleveland Clinic).  
 
Assays for cell proliferation and senescene 
 For the proliferation assay, cells were plated in 96-well plates at ~50% confluence two days 
prior to the assay. Cells were incubated with a nucleoside analog of thymidine, 5-ethynyl-2´-                                                                                                               
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deoxyuridine (EdU), for 60 minutes followed by fixation and staining for EdU-incorporated cells 
using the ClickiT™ EdU Assay kit (Invitrogen).  
For the senescence assay, cells were plated in 12-well plates, fixed and incubated at 37
oC 
with staining solution containing the X-Gal substrate (BioVision).  The development of blue 
color was detected visually with a microscope.  
 
Immunoblotting, immunofluorescence and comet assay 
For  Western  blotting,  antibodies  were  used  for  the  following  human  proteins:  ERK1  and 
phospho-ERK1/2, RR1, RR2 from Santa Cruz Biotechnology (sc-42, sc-93, sc-7383, sc-11733, 
sc-10844, respectively); TS (ab7398-1) from Abcam, TK1 (34003) from EMD Chemical Group; 
ATM  (2873)  and  phospho-ATM-Ser1981  (4526)  from  Cell  Signaling.  Membranes  were 
developed using alkaline phosphatase-conjugated secondary antibodies and the Alpha-Innotech 
FluorChem HD2
® imaging system. For immunofluorescence-based analysis, formaldehyde-fixed 
cells were stained with H2AX--specific antibodies (05-636) from Millipore according to the 
manufacturer’s  recommendations  followed  by  staining  with  4',6-diamidino-2-phenylindole 
(DAPI). Alkaline comet assay was performed using Trevigen CometAssay® HT kit (4252-040-
K) according to the manufacturer’s recommendations. 
 
Nucleotide triphosphate quantification 
Nucleotide triphosphates were extracted and assayed as described previously (17, 18).    All 
measurements were performed in quadruplicate, and data recorded as standard deviation of the 
mean.  For convenience data are presented in the respective figures in terms of arbitrary units.                                                                                                                
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However, the actual pool sizes determined, in pmol/cell, were comparable to values previously 
reported for cultured mammalian cells (18). 
 
Chromatin Immunoprecipitation 
 Interactions between RB, H3K9
3Me and the promoters of TS, RR1 and RR2 were assessed using 
the  EZ-Chip  kit  from  Millipore  according  to  the  manufacturer’s  recommendations  with  the 
following antibodies: IgG (Santa Cruz Biotechnology, sc-2027), RB (Santa Cruz Biotechnology, 
sc-73598) or H3K9
3Me (Millipore, 07-442).  The following primers were used for the PCR:  TS 
5’-TTC CCG GGT TTC CTA AGA CT-3’ and 5’-TGG ATC TGC CCC AGG TAC T-3’;  RR1 
5’-GCT GAC AGG GCG GAA G-3’ and 5’-GGA AGG GGA TTT GGA TTG TT-3’; RR2 5’-
CCT CAC TCC AGC AGC CTT TA-3’ and 5’-CAC CAA CCT CGT TGG CTA AG-3’ 
 
FACS Analysis 
Cells were pelleted, resuspended in phosphate-buffered saline containing 0.5% fetal calf serum 
(PBS-S) and fixed in 70% ethanol. The cells were washed in  PBS-S, resuspended in PBS-S 
containing propidium iodide (Sigma-Aldrcih), incubated for 30 min at 37°C and analyzed using 
a FACScan fluorescence activated cells sorter (BD Biosciences). 
 
Results 
HRAS
G12V-overexpressing senescent WI-38 cells possess low dNTP pools and under-express key 
enzymes required for deoxyribonucleoside biosynthesis 
To  determine  whether  NHF  undergoing  oncogene-induced  senescence  possess  low  levels  of 
endogenous  nucleotide  pools,  we  assessed  amounts  of  intracellular  ribo-  and                                                                                                                
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deoxyribonucleoside  triphosphates  in  WI-38  cells  transduced  with  control  or  HRAS
G12V-
expressing lentiviral vector 6 days after infection, i.e. soon after the emergence of senescent 
phenotypes (Figure 1A).  We found that although overexpression of HRAS
G12V depleted both 
pools of nucleotide triphosphates, levels of rNTPs were affected less severely than dNTPs levels 
(20%-50% versus 60%-80% reduction, Figure 1B).  Unlike de novo ribonucleotide biosynthesis 
pathways  that  include  multiple  enzymatic  activities,  the  entire  de  novo  biosynthesis  of 
deoxyribonucleosides is largely controlled by only two enzymes.  Ribonucleotide reductase (RR) 
converts  ADP,  CDP,  GDP  and  UDP  respectively  to  dADP,  dCDP,  dGDP  and  dUDP  (19).  
Thymidylate synthase (TS) catalyzes the de novo synthesis of dTMP from dUMP (20).  Thus, we 
measured  expression  levels  of  TS  and  both  subunits  of  RR  (RR1  and  RR2)  in  control  and 
HRAS
G12V-expressing WI-38 cells by western blotting 6 days post-infection. We found that like 
dNTP pools, the levels of these enzymes were significantly depleted in senescent fibroblasts 
(Figure 1C). Additionally, the expression of a gene encoding thymidine kinase 1 (TK1), a key 
enzyme required for the salvage deoxyribonucleoside synthesis (21), was also down-regulated in 
senescent cells. 
 
Co-expression of TS, RR1 and RR2 or addition of deoxyribonucleosides reduces DNA damage 
and OIS in NHF 
The highest expression of thymidylate synthase and ribonucleotide reductase has been reported 
in the S-phase of the cell cycle (22, 23). Therefore, depletion of TS, RR, and dNTP pools in 
HRAS
G12V-WI-38 cells may be a consequence of G0/G1 or G1/S cell cycle arrest induced by 
HRAS
G12V (Figure 1D). Alternatively, this depletion may be a cause of proliferation arrest and 
senescence  in  cells  overexpressing  HRAS
G12V.    To  discern  between  these  possibilities,  we                                                                                                                
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attempted to restore TS and RR levels in HRAS
G12V-WI-38 fibroblasts following by assessment 
of senescence-associated phenotypes. To this end, we concurrently transduced WI-38 cells with 
cDNAs for TS, RR1 and RR2 (hereafter TRR) or in parallel with three empty vectors (hereafter 
3V).  Two days after infection, 3V and TRR cells were super-infected with viruses containing 
empty vector or HRAS
G12V-expressing vector.  Activity of HRAS
G12V in 3V and TRR cells was 
monitored by measuring the levels of phosphorylated ERK1/2 that appeared to be the same in 
both types of cells (Figure 2A). Expression of  TS,  RR1 and RR2 proteins was  followed  by 
western blotting.   As shown in Figure 2A, super-infection of HRAS
G12V in TRR-cells did not 
significantly  change  total  (exogenous  and  endogenous)  amounts  of  these  proteins.  
Consequently,  dNTP  levels  in  HRAS
G12V-TRR  cells  were  2-2.5-fold  higher  than  those  in 
HRAS
G12V-3V  cells  (Figure  2B).    Moreover,  the  number  of  cells  exhibiting  DNA  damage 
detected by the comet assay or by staining with H2AX--specific antibodies or the number of 
SA--Gal-positive  cells  was  also  2-3  fold  lower  in  HRAS
G12V-TRR  versus  HRAS
G12V-3V 
populations (Figure 2C). Most importantly, inhibition of proliferation by HRAS
G12V in TRR cells 
was only partial as compared to the complete and stable proliferation arrest of HRAS
G12V-3V 
cells  (Figure  2DE,  Supplemental  Figure  1A).  Thus,  restoration  of  thymidylate  synthase  and 
ribonucleotide  reductasse  levels  in  cells  overexpressing  HRAS
G12V  results  in  the  substantial 
suppression of senescence phenotypes. 
  To independently verify the importance of maintaining high dNTP pools for suppression 
of DNA damage and OIS, we attempted to restore intracellular dNTPs in WI-38-HRAS
G12V cells 
by  supplementing  their  culture  media  with  deoxyribonucleosides  starting  the  next  day  after 
infection with HRAS
G12V-encoding virus, i.e. prior to the emergence of senescence-associated 
phenotypes. Culture media containing or not deoxyribonucleosides were replaced with the fresh                                                                                                                
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ones respectively containing or not deoxyribonucleosides every 2 days for the duration of the 
experiment. Incubation with deoxyribonucleosides did not affect the activity of HRAS
G12V as 
was determined by the absence of changes in the amounts of phosphorylated ERK1/2 between 
treated and untreated  populations of  cells (Figure 3A). However, this treatment did  increase 
intracellular  amounts  of  dNTP  pools  1.5-2.5  fold  (Figure  3B)  and  decreased  the  number  of 
H2AX--  and  comet-positive  cells  and  cells  exhibiting  SA--Gal  activity  in  the  treated 
populations (Figure 3C).  Accordingly, HRAS
G12V was less effective in suppressing proliferation 
of WI-38 cells growing in the medium supplemented with deoxyribonucleosides compared to the 
untreated cells that underwent proliferation arrest (Figure 3DE, Supplemental Figure 1B).   
Therefore, even partial restoration of suppressed dNTP pools via either overexpression of 
thymidylate  synthase  and  ribonucleotide  reductase  or  incubation  with  exogenous 
deoxyribonucleosides  reduced  DNA  damage  and  the  full-scale  manifestation  of  oncogene-
induced senescence in WI-38 cells. 
  In order to generalize our  findings, we utilized  a different  type of NHF, primary  BJ 
fibroblasts  ectopically  expressing  the  human  telomerase  reverse  transcriptase  gene  and 
tamoxifen-inducible  RAS
G12V-ER
TAM  chimera  gene  (BJ-ET-RAS
G12V-ER
TAMcells).    Upon 
activation  of  HRAS
G12V  via  addition  of  4-hydroxytestosterone  (4-OHT)  (Figure  4A), 
proliferation of these cells was reduced gradually until reaching an arrest at approximately day 8 
(Figure 4B). The arrest was accompanied by changes in cell morphology, increased SA--Gal 
activity and increased DNA damage visualized by antibodies to H2AX- Figure 4C). At the 
same time, continuous presence of deoxyribonucleosides in growth media, while not affecting 
HRAS
G12V activation (Figure 4A), reduced inhibition of cell proliferation and other senescence-
associated phenotypes (Figure 4BC) similarly to WI-38 cells.                                                                                                                
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Depletion of TS and RR2 causes senescence in NHF  
To understand whether down-regulation of thymidylate synthase and ribonucleotide reductase  is 
sufficient to cause DNA damage and emergence of senescent phenotypes in NHF with normal, 
not  hyper-stimulated  DNA  replication,  we  depleted  amounts  of  thymidylate  synthase  and 
ribonucleotide reductase  in WI-38 fibroblasts via co-infection with vectors carrying shRNAs for 
thymidylate synthase and ribonucleotide reductase subunit  R2and compared these cells with 
cells infected with control shRNA vector. Depletion of TS and RR2 (Figure 5A) led to stable 
proliferation  arrest  (Figure  5B,  Supplemental  Figure  1C),  albeit  with  longer  latent  period 
compared to HRAS
G12V-WI-38 cells (9-11 days versus 4-6 days).  Arrested fibroblasts exhibited 
DNA  damage  (as  was  visualized  by  staining  with  antibodies  to  H2AX-  (Figure  5C)  and 
elevated activity of SA--Gal (Figure 5C), however, the proportion of SA--Gal- and H2AX--
positive cells was also lower compared to WI-38 cells arrested by overexpression of HRAS
G12V 
(compare Figs 2, 3 and 5).  
 
Overexpression or thymidylate synthase and ribonucleotide reductase or addition of exogenous 
deoxyribonucleosides does not suppress quiescence in normal human fibroblasts 
We were interested in addressing the role of thymidylate synthase and ribonucleotide reductase  
overexpression  in  suppressing  quiescence  of  NHF,  a  form  of  temporary  arrest  of  DNA 
replication that is not associated with DNA damage and can be achieved by serum deprivation 
(4, 24).   Incubation of WI-38 cells in medium devoid of fetal bovine serum (FBS) for 48 hours 
resulted in substantial down-regulation of TS, RR1 and RR2 (Figure 6A), however, no increase 
was detected  in the  number of  H2AX--positive cells (Figure 6B), suggesting that no DNA                                                                                                                
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damage  was  present.  Importantly,  continuous  supplementation  with  deoxyribonucleosides  of 
FBS-free culture media did not even partially affect proliferation arrest as was determined by 
EdU incorporation at day 5 after replacing the culture medium (Figure 6C). Accordingly, the 
same assay demonstrated that proliferation of TRR-expressing WI-38 cells (described above) 
was  suppressed  by  serum  withdrawal  as  efficiently  as  the  proliferation  of  control  3V  cells 
(Figure 6C). Thus, we concluded that unlike oncogene-induced senescence, overexpression of 
thymidylate  synthase  and  ribonucleotide  reductase  or  supplementation  with 
deoxyribonucleosides does not suppress quiescence in normal human fibroblasts. 
 
Promoters of TS, RR1 and RR2 interact with RB and undergo heterochromatization in senescent 
HRAS
G12V-WI38 cells 
Transcription levels of RR1, RR2 and TS can be up-regulated by ectopic expression of E2F1 
(25). Promoters of some E2F-responsive genes  have  been  shown to interact with RB tumor 
suppressor proteins in NHF undergoing HRAS
G12V-induced senescence (26).  Thus, to identify 
whether silencing of TRR genes in HRAS
G12V-WI38 senescent fibroblasts occurs via interactions 
with RB, we performed chromatin immunoprecipitation in these and vector cells with control 
antibodies, antibodies to RB or tri-methylated lysine 9 of histone H3 (H3K9
3Me), a hallmark of 
heterochromatin (27) and senescence-associated heterochromatin foci (26).  After precipitation, 
the chromatin was de-crosslinked and the purified DNA was probed in semi-quantitative PCR 
with primers spanning E2F1-binding sites in the promoters of RR1, RR2 and TS genes. By this 
method, we demonstrated substantial enrichment of the promoter regions of all three genes in 
chromatin precipitated with RB- or H3K9
3Me-specific antibodies from HRAS
G12V-senescent but                                                                                                                
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not  vector  cells  (Figure  7),  suggesting  that  RB  binding  and  formation  of  heterochromatin 
contribute to silencing of TRR genes in senescent HRAS
G12V-WI38 cells. 
 
Discussion 
DNA damage induced by ectopic expression of activated RAS or RAF oncoproteins in normal 
mammalian cells has been considered as a major cause of senescence, a fail-safe mechanism for 
suppressing tumor development at a premalignant stage (1,2).  In the current study, we tested 
hypothesis that at least one of the major mediators of HRAS
G12V DNA damage- and senescence-
inducing activity is down-regulation of dNTP pools.  Decrease in the amounts of intracellular 
deoxyribonuclotides  in  OIS  cells  may  cause  DNA  damage  and  affect  DNA  replication  fork 
progression (which was described in fibroblasts undergoing HRAS
G12V-induced senescence [6]) 
via  several  interrelated  mechanisms.  The  most  obvious  one  is  that  dNTP  deficiency  slows 
processivity or even completely arrests DNA polymerase.  However, this is an unlikely scenario 
since inhibition of DDR proteins ATM or CHK2 abolishes HRAS
G12V-induced senescence in 
NHF presumably via dNTP-independent mechanism (4-7).  Most likely, stalling or collapse of 
the replication fork in a senescent cell occurs due to the DNA damage sites pre-existent to the 
current DNA replication, and these pre-existent lesions may originate from dNTP depletion. For 
example, it has been shown that inhibition of TS activity results in depletion of dTTP pools and 
in symmetrical increase in the amounts of deoxyuridine triphosphates which are utilized instead 
of dTTP for DNA polymerization (28).  The incorporated uracil is removed via the uracil base 
excision repair (BER) system, however, if the number of incorporated uracil bases is high, the 
repair machinery is overwhelmed and generates abasic sites, as well as double- and/or single-
strand breaks (15), which would ultimately cause replication stress and affect the replication fork                                                                                                                
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progression during the following round of DNA replication.  Similarly, inhibition of RR and 
subsequent depletion of dATP, dGTP and dCTP pools lead to nucleotide misincorporation and 
activation of the mismatch repair system (MMR) (29) that, if overwhelmed, would also generate 
double and/or single strand DNA breaks (30). Additionally, both BER and MMR systems utilize 
de novo DNA synthesis to fill the gaps generated in the course of DNA repair (31). Low levels 
of dNTPs would affect fidelity of this synthesis and subsequently, DNA repair in general.  
The proposed mechanisms of generation of DNA damage in OIS cells are in a good 
agreement with previously published observations.  For instance, as was mentioned above, a 
large  number  of  HRAS
G12V-expressing  cells  were  arrested  with  partly  replicated  DNA, 
suggesting stalling or a collapse of replication fork (6).  DNA hyper-replication (multiple firing 
of  the  same  replication  origin)  was  proposed  to  be  a  primary  cause  for  this  phenotype  (6).  
Stalling or collapse of the replication fork and subsequent induction of the S-phase checkpoint 
can  be  induced  by  pharmacological  inhibition  of  thymidylate  synthase  or  ribonucleotide 
reductase  via mechanisms described above in cells with normal, not hyper-stimulated, DNA 
replication.  Therefore, it is conceivable that under the conditions of low dNTP pools multiple 
origin  firings  and  subsequently  multiple  replication  forks  would  generate  even  higher  DNA 
damage.  Accordingly, fragile sites in OIS cells were more prone to undergoing mutations than 
any other regions of the genome (6). Similarly, pharmacological  inhibition of ribonucleotide 
reductase    has  been  shown  to  disproportionally  increase  mutagenesis  of  genomic  regions 
containing fragile sites (32, 33).   
We demonstrated that even partial restoration of depleted intracellular dNTP pools  is 
sufficient  for  substantial  suppression  of  DNA  damage  and  senescence.    Despite  significant 
ectopic overexpression of thymidylate synthase and ribonucleotide reductase  or incubation with                                                                                                                
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excessive amounts of deoxyribonucleosides, we were unable to completely restore dNTP pools 
in cells undergoing senescence. Complete reconstitution  may require  involvement of salvage 
pathway enzymes (especially for phosphorylation of exogenously added nucleosides) that, like 
thymidine kinase 1 (21), (Figure 1C) may be suppressed in senescent cells, or enzymes involved 
in biosynthesis of ribonucleotides.  Interestingly the genomes of herpes viruses that replicate 
their DNA in quiescent cells with depleted dNTP pools often encode enzymes for both de novo 
and salvage pathways, including homologues to cellular RR1 and RR2, thymidylate synthase, 
thymidine kinase, dihydrofolate reductase and dUTP pyrophosphatase (34).  However, we could 
not recapitulate expression of all of these genes in our experimental settings since overexpression 
of additional cDNAs in WI-38 cells affected their normal proliferation rates.   
It  is  known  that  transformed  cells  utilize  aerobic  glycolysis  as  a  major  pathway  for 
biosynthesis of adenosine triphosphate, a process called the “Warburg effect” (35).  Recently, 
several groups reported that the enhanced rates of glycolysis occur largely due to the increased 
demand of a transformed cell for macromolecule components including nucleotides that can be 
synthesized from glycolytic metabolites (36, 37).  Bypassing senescence is considered an initial 
step in oncogenic transformation and our data suggest that elevation of nucleotide levels is an 
important prerequisite for this step. Thus switching to aerobic glycolysis to increase nucleotide 
pools may be required already at early stages of tumorigenesis.  
Our  results  suggest  that  both  nucleotide  depletion  and  active  DNA  replication  are 
required for efficient induction of DNA damage and OIS. Concurrent depletion of TS and RR2 
in WI-38 fibroblasts with normal DNA replication induced senescence with longer latent period 
than overexpression of HRAS
G12V, and senescent populations contained lower fraction of H2AX-
-positive and SA--Gal-positive cells compared to WI-38 cells overexpressing HRAS
G12V (with                                                                                                                
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presumably hyper-replicated DNA) (Figs 2 and 5). Furthermore, serum withdrawal-arrested WI-
38 cells, with no DNA replication, do not undergo DNA damage and senescence despite down-
regulation  of  TS,  RR1  and  RR2  (Figure  5).  Accordingly,  ectopic  overexpression  of  these 
enzymes  in  quiescent  WI-38  cells  or  exogenous  addition  of  deoxyribonucleosides  into  their 
media did not overcome this form of proliferation arrest.   
We demonstrated that promoters of TS, RR1 and RR2  in HRAS
G12V-WI38 senescent 
cells  interacted  with  RB  tumor  suppressor  proteins  and  were  enriched  with  heterochromatin 
marker H3K9
3Me (Figure 7).  RB has been shown to play an essential role in HRAS
G12V-induced 
senescence  by  binding  to  the  promoters  of  several  E2F-repsonsive  genes  and  establishing 
repressive chromatin at the target loci (26). Thus, our findings may offer a novel connection 
between  RB  activation  and  repression  of  nucleotide  metabolism  ultimately  resulting  in  the 
increased DNA damage and senescence.  
Taken together, our data provide a previously unidentified mechanism for the induction 
of DNA damage and oncogene-induced senescence. 
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Figure Legends 
Figure 1. Senescent HRAS
G12V-WI38 fibroblasts possess low NTP pools and under-express key 
enzymes  for  deoxyribonucleoside  metabolism.  (A)  Cells  were  infected  with  empty  lentiviral 
vector (V) or lentiviral vector encoding HRAS
G12V (R). Six days after infection, cells were fixed 
and  processed  to  visualize  SA--Gal  activity.  Numbers  indicate  a  percentage  of  SA--Gal-
positive cells. The numbers were derived from counting cells in multiple view fields. (B) Cells 
infected as in (a) were harvested 6 days after infection and intracellular NTPs were extracted and 
quantified.  Amounts of each NTP were normalized by the amounts of a corresponding NTP 
detected in vector cells. (C) Cells infected as in (a) were harvested 6 days after infection, lysed 
and total protein extracts were probed in western blotting with antibodies shown on the right. (D) 
Cells infected as in (a) were collected, fixed, stained with propidium iodide and analyzed by flow 
cytometry. 
 
Figure 2.  Co-expression of TS, RR1 and RR2 reduce OIS phenotypes  in HRAS
G12V-WI38 
fibroblasts.  (A)  Cells  were  infected  with  control  vectors  three  times  (3V)  or  with  vectors 
expressing cDNA  for TS, RR1 and RR2 cDNAs (TRR).  Forty-eight hours later, cells were 
super-infected with the empty vector (V) or HRAS
G12V (RAS). Six days after second infection, 
cells  were  harvested,  lysed  and  total  protein  extracts  were  probed  in  western  blotting  with 
antibodies indicated on the left.  (B) Cells were infected as in (a). Six days after the second 
infection,  intracellular  dNTPs  were  extracted  and  quantified.    Amounts  of  each  dNTP  from 
HRAS
G12V-infected cells were normalized by the amounts of corresponding dNTP detected in 
3V-Vector cells (left columns) or TRR-Vector cells (right columns). (C) Cells were infected as 
in (a). Six days after infection, cells were fixed and processed to visualize SA--Gal activity,                                                                                                                
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fixed and stained with H2AX-γ-specific antibodies and DAPI or subjected to the comet assay 
(the type of assay is shown on the left). Numbers indicate percentage of positive cells in each 
assay. The numbers were derived from counting cells in multiple view fields. (D-E) Cells were 
infected as in (a). Two days after second infection, cells were plated in 12-well plate in triplicate 
and counted every other day for 6 days.  Numbers below the graph correspond to the days post-
infection. In parallel, at day 7 post-infection, cells were assayed for proliferation rates (EdU 
incorporation). In each population, the number of positive cells was divided by the number of 
total cells. 
 
Figure  3.  Exogenous  deoxyribonucleosides  reduce  OIS  phenotypes  in  HRAS
G12V-WI38 
fibroblasts. (A) Cells were infected with empty lentiviral vector (V) or lentiviral vector encoding 
HRAS
G12V (R).  Next day after infection, 100 M of each deoxyribonucleoside was added (+dN) 
or not to the culture media and media were replaced with the fresh one respectively containing or 
not deoxyribonucleosides every 2 days.  Six days after infection, cells were harvested, lysed and 
total protein extracts were probed in western blotting with antibodies indicated on the left.  (B) 
Cells were infected and treated as in (a) followed by dNTPs extraction and quantification 6 day 
after infection.  All dNTP amounts were normalized by the amounts detected in “vector” cells. 
(C) Cells were  infected and treated as  in (a).  Six days  after  infection, cells were  fixed and 
processed to visualize SA-β-Gal activity or fixed and stained with H2AX-γ-specific antibodies 
and DAPI or subjected to the comet assay (the type of assay is shown on the left). Numbers 
indicate percentage of positive cells. The numbers were derived from counting cells in multiple 
view fields. (D-E) Cells were infected and treated as in (a). Two days after infection, cells were 
plated in 12-well plate in triplicate and counted every other day for 6 days.  Numbers below the                                                                                                                
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graph  correspond  to  the  days  post-infection.  In  parallel,  at  day  6  post-infection,  cells  were 
assayed for proliferation rates (EdU incorporation). In each population, the number of positive 
cells was divided by the number of total cells. 
 
Figure 4. Exogenous deoxyribonucleosides reduce OIS phenotypes in BJ-ET-RAS
G12V-ER
TAM 
fibroblasts. (A) Untreated cells (UN), cells treated with 0.1 M of 4-hydroxytestosterone (4-
OHT) or with 4-hydroxytestosterone and 100 M of each deoxyribonucleoside (4-OHT+dN). 
Seven days after addition of the chemicals, cells were harvested, lysed and total protein extracts 
were probed in western blotting with antibodies indicated on the left.   (B) Cells were plated in 
12-well plate in triplicate and treated as in (a) and counted once in two days for 8 days.  Numbers 
below the graph correspond to the days post-infection. (C) Cells were treated as in (a) for 7 days. 
Cells were fixed and processed to visualize SA-β-Gal activity or fixed and stained with H2AX-γ- 
specific  antibodies  and  DAPI  (the  type  of  staining  is  shown  on  the  left).  Numbers  indicate 
percentage of positive cells. The numbers were derived from counting cells in multiple view 
fields. 
 
Figure 5.  Deficiency of TS and RR2 induces senescence in WI-38 fibroblasts. (A) Cells were 
infected  with  control  shRNA  lentiviral  vector  (Cl)  or  with  combination  of  vectors  carrying 
shRNAs for TS or RR2 shRNAs (T+R2).   Two days after infection, cells were harvested, lysed 
and total protein extracts were probed in western blotting with antibodies indicated on the left. 
(B) Cells were infected as in (a). Two days after infection cells were plated in 12-well plate in 
duplicate and counted every other day for 9 days. Numbers below the graph correspond to the 
days post-infection.  (C) Cells were infected as in (a). Ten days after infection, cells were fixed                                                                                                                
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and  processed  to  visualize  SA--Gal  activity  or  fixed  and  stained  with  H2AX-γ-specific 
antibodies  and  DAPI  (type  of  assay  is  shown  on  the  left).  Numbers  indicate  percentage  of 
positive cells. The numbers were derived from counting cells in multiple view fields. 
 
Figure 6. Co-expression of TS, RR1 and RR2 or addition of exogenous deoxyribonucleosides 
does not affect quiescence of WI-38 fibroblasts. (A) Cells were incubated in culture medium 
containing 10% or 0% FBS for 2 days. Cells were collected, lysed and total protein extracts were 
probed in western blotting with antibodies indicated on the left. (B) Cells treated as in (a) were 
fixed and stained with antibodies for H2AX-
in multiple view fields. (C) Uninfected WI-38 cells, 3V WI-38 cells and TRR WI-38 cells were 
grown  in  the  media  containing  10%  or  0%  FBS  supplemented  or  not  with  100  M  of 
deoxyribonucleosides (+dN)  for a period of 5 days. Cell proliferation was  assessed  by EdU 
incorporation assay. The numbers were derived from counting cells in multiple view fields.  
 
Figure 7.  Promoter regions of TS, RR1 and RR2 are enriched with RB and tri-methylated lysine 
9 of histone H3. (A) Cells were infected with empty lentiviral vector (V) or lentiviral vector 
encoding HRAS
G12V (R).  Six days after infection, cells were harvested, lysed and total protein 
extracts  were  probed  in  western  blotting  with  antibodies  shown  on  the  left.  (B)  Cells  were 
infected as in (a). Six days after infection, cells were cross-linked, lysed, and chromatin was 
immunoprecipitated with the antibodies shown on the top followed by the reversal of the cross-
linking  and  DNA  isolation.  DNA  obtained  from  chromatin  immunoprecipitated  with  the 
antibodies designated on the top or 0.1% of the input DNA (Inp.) was used in PCR with the 
primers specific to the promoter regions of the genes shown on the left.  